Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response. [electronic resource]
Producer: 20150109Description: 2251-4 p. digitalISSN:- 1476-5551
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Drug Resistance, Neoplasm -- genetics
- Female
- Flavonoids -- therapeutic use
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Middle Aged
- Mitochondria -- physiology
- Piperidines -- therapeutic use
- bcl-X Protein -- genetics
No physical items for this record
Publication Type: Letter; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.